Global COVID-19 Inactivated Vaccine Market Research Report 2026 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2033
ReportID: 1025125
|
Published Date: 2025/12/12
|
No. of Pages: 165
|
Categories: IT & Telecommunication
|
Format : 
The A2Z Market Research report on “Global COVID-19 Inactivated Vaccine Market Report 2023 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029” offers strategic visions into the global COVID-19 Inactivated Vaccine market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2023 to 2029. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading COVID-19 Inactivated Vaccine product vendors, and their latest developments.
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2023 to 2029. The study highlights current market trends for COVID-19 Inactivated Vaccine and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global COVID-19 Inactivated Vaccine market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the COVID-19 Inactivated Vaccine market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global COVID-19 Inactivated Vaccine market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in COVID-19 Inactivated Vaccine market are:
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Moderna, Inc.
Curevac
ImmunoPrecise
Market segmentation by Type:
In Clinical Trials
Out-of-Clinical Trials
Market segmentation by Application:
Hospital
Clinic
Other
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2023 to 2029. The study highlights current market trends for COVID-19 Inactivated Vaccine and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global COVID-19 Inactivated Vaccine market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the COVID-19 Inactivated Vaccine market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global COVID-19 Inactivated Vaccine market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in COVID-19 Inactivated Vaccine market are:
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Moderna, Inc.
Curevac
ImmunoPrecise
Market segmentation by Type:
In Clinical Trials
Out-of-Clinical Trials
Market segmentation by Application:
Hospital
Clinic
Other
Table of Content
Global COVID-19 Inactivated Vaccine Market Research Report 2023 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 COVID-19 Inactivated Vaccine Market Overview
1.1 Product Overview and Scope of COVID-19 Inactivated Vaccine
1.2 COVID-19 Inactivated Vaccine Market Segmentation by Type
1.2.1 Global Production Market Share of COVID-19 Inactivated Vaccine by Type in 2023
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 COVID-19 Inactivated Vaccine Market Segmentation by Application
1.3.1 COVID-19 Inactivated Vaccine Consumption Market Share by Application in 2023
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 COVID-19 Inactivated Vaccine Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of COVID-19 Inactivated Vaccine (2018-2029)
Chapter 2 Global Economic Impact on COVID-19 Inactivated Vaccine Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global COVID-19 Inactivated Vaccine Market Competition by Manufacturers
3.1 Global COVID-19 Inactivated Vaccine Production and Share by Manufacturers (2023 and 2023)
3.2 Global COVID-19 Inactivated Vaccine Revenue and Share by Manufacturers (2023 and 2023)
3.3 Global COVID-19 Inactivated Vaccine Average Price by Manufacturers (2023 and 2023)
3.4 Manufacturers COVID-19 Inactivated Vaccine Manufacturing Base Distribution, Production Area and Product Type
3.5 COVID-19 Inactivated Vaccine Market Competitive Situation and Trends
3.5.1 COVID-19 Inactivated Vaccine Market Concentration Rate
3.5.2 COVID-19 Inactivated Vaccine Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global COVID-19 Inactivated Vaccine Production, Revenue (Value) by Region (2018-2023)
4.1 Global COVID-19 Inactivated Vaccine Production by Region (2018-2023)
4.2 Global COVID-19 Inactivated Vaccine Production Market Share by Region (2018-2023)
4.3 Global COVID-19 Inactivated Vaccine Revenue (Value) and Market Share by Region (2018-2023)
4.4 Global COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.5 North America COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.6 Europe COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.7 China COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.8 Japan COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.9 Southeast Asia COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.10 India COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
Chapter 5 Global COVID-19 Inactivated Vaccine Supply (Production), Consumption, Export, Import by Regions (2018-2023)
5.1 Global COVID-19 Inactivated Vaccine Consumption by Regions (2018-2023)
5.2 North America COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.3 Europe COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.4 China COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.5 Japan COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.6 Southeast Asia COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.7 India COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
Chapter 6 Global COVID-19 Inactivated Vaccine Production, Revenue (Value), Price Trend by Type
6.1 Global COVID-19 Inactivated Vaccine Production and Market Share by Type (2018-2023)
6.2 Global COVID-19 Inactivated Vaccine Revenue and Market Share by Type (2018-2023)
6.3 Global COVID-19 Inactivated Vaccine Price by Type (2018-2023)
6.4 Global COVID-19 Inactivated Vaccine Production Growth by Type (2018-2023)
Chapter 7 Global COVID-19 Inactivated Vaccine Market Analysis by Application
7.1 Global COVID-19 Inactivated Vaccine Consumption and Market Share by Application (2018-2023)
7.2 Global COVID-19 Inactivated Vaccine Consumption Growth Rate by Application (2018-2023)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 COVID-19 Inactivated Vaccine Manufacturing Cost Analysis
8.1 COVID-19 Inactivated Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of COVID-19 Inactivated Vaccine
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 COVID-19 Inactivated Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of COVID-19 Inactivated Vaccine Major Manufacturers in 2023
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global COVID-19 Inactivated Vaccine Market Forecast (2023-2029)
12.1 Global COVID-19 Inactivated Vaccine Production, Revenue Forecast (2023-2029)
12.2 Global COVID-19 Inactivated Vaccine Production, Consumption Forecast by Regions (2023-2029)
12.3 Global COVID-19 Inactivated Vaccine Production Forecast by Type (2023-2029)
12.4 Global COVID-19 Inactivated Vaccine Consumption Forecast by Application (2023-2029)
12.5 COVID-19 Inactivated Vaccine Price Forecast (2023-2029)
Chapter 13 Appendix
Global COVID-19 Inactivated Vaccine Market Research Report 2023 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 COVID-19 Inactivated Vaccine Market Overview
1.1 Product Overview and Scope of COVID-19 Inactivated Vaccine
1.2 COVID-19 Inactivated Vaccine Market Segmentation by Type
1.2.1 Global Production Market Share of COVID-19 Inactivated Vaccine by Type in 2023
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 COVID-19 Inactivated Vaccine Market Segmentation by Application
1.3.1 COVID-19 Inactivated Vaccine Consumption Market Share by Application in 2023
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 COVID-19 Inactivated Vaccine Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of COVID-19 Inactivated Vaccine (2018-2029)
Chapter 2 Global Economic Impact on COVID-19 Inactivated Vaccine Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global COVID-19 Inactivated Vaccine Market Competition by Manufacturers
3.1 Global COVID-19 Inactivated Vaccine Production and Share by Manufacturers (2023 and 2023)
3.2 Global COVID-19 Inactivated Vaccine Revenue and Share by Manufacturers (2023 and 2023)
3.3 Global COVID-19 Inactivated Vaccine Average Price by Manufacturers (2023 and 2023)
3.4 Manufacturers COVID-19 Inactivated Vaccine Manufacturing Base Distribution, Production Area and Product Type
3.5 COVID-19 Inactivated Vaccine Market Competitive Situation and Trends
3.5.1 COVID-19 Inactivated Vaccine Market Concentration Rate
3.5.2 COVID-19 Inactivated Vaccine Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global COVID-19 Inactivated Vaccine Production, Revenue (Value) by Region (2018-2023)
4.1 Global COVID-19 Inactivated Vaccine Production by Region (2018-2023)
4.2 Global COVID-19 Inactivated Vaccine Production Market Share by Region (2018-2023)
4.3 Global COVID-19 Inactivated Vaccine Revenue (Value) and Market Share by Region (2018-2023)
4.4 Global COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.5 North America COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.6 Europe COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.7 China COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.8 Japan COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.9 Southeast Asia COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
4.10 India COVID-19 Inactivated Vaccine Production, Revenue, Price and Gross Margin (2018-2023)
Chapter 5 Global COVID-19 Inactivated Vaccine Supply (Production), Consumption, Export, Import by Regions (2018-2023)
5.1 Global COVID-19 Inactivated Vaccine Consumption by Regions (2018-2023)
5.2 North America COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.3 Europe COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.4 China COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.5 Japan COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.6 Southeast Asia COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
5.7 India COVID-19 Inactivated Vaccine Production, Consumption, Export, Import by Regions (2018-2023)
Chapter 6 Global COVID-19 Inactivated Vaccine Production, Revenue (Value), Price Trend by Type
6.1 Global COVID-19 Inactivated Vaccine Production and Market Share by Type (2018-2023)
6.2 Global COVID-19 Inactivated Vaccine Revenue and Market Share by Type (2018-2023)
6.3 Global COVID-19 Inactivated Vaccine Price by Type (2018-2023)
6.4 Global COVID-19 Inactivated Vaccine Production Growth by Type (2018-2023)
Chapter 7 Global COVID-19 Inactivated Vaccine Market Analysis by Application
7.1 Global COVID-19 Inactivated Vaccine Consumption and Market Share by Application (2018-2023)
7.2 Global COVID-19 Inactivated Vaccine Consumption Growth Rate by Application (2018-2023)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 COVID-19 Inactivated Vaccine Manufacturing Cost Analysis
8.1 COVID-19 Inactivated Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of COVID-19 Inactivated Vaccine
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 COVID-19 Inactivated Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of COVID-19 Inactivated Vaccine Major Manufacturers in 2023
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global COVID-19 Inactivated Vaccine Market Forecast (2023-2029)
12.1 Global COVID-19 Inactivated Vaccine Production, Revenue Forecast (2023-2029)
12.2 Global COVID-19 Inactivated Vaccine Production, Consumption Forecast by Regions (2023-2029)
12.3 Global COVID-19 Inactivated Vaccine Production Forecast by Type (2023-2029)
12.4 Global COVID-19 Inactivated Vaccine Consumption Forecast by Application (2023-2029)
12.5 COVID-19 Inactivated Vaccine Price Forecast (2023-2029)
Chapter 13 Appendix
Published On:2025/12/12
Base Year:2025
Historical Data:2019-2024
No of Pages:165
Price
Global COVID-19 Inactivated Vaccine Market Research Report 2026 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2033
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
